Results 101 to 110 of about 6,478 (222)

Ocular hypotensive effect, preservation of visual fields, and safety of adding dorzolamide to prostaglandin therapy for twelve months

Clinical Ophthalmology, 2011
Kenji Inoue1,3, Mieko Masumoto1,3, Masato Wakakura1, Goji Tomita2, On behalf of the Ochanomizu Ophthalmology Study Group31Inouye Eye Hospital, Tokyo, Japan; 2Department of Ophthalmology, Toho University School of Medicine, Tokyo, Japan; 3Ochanomizu ...
Kenji Inoue, Mieko Masumoto, Masato Wakakura, et al   +3 more
doaj  

Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma

Clinical Ophthalmology, 2008
Jason Yeh1, Daniel Kravitz2, Brian Francis11Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 2Tulane University, School of Medicine, New Orleans, LA, USAAbstract: Glaucoma is a multifactorial optic ...
Jason Yeh, Daniel Kravitz, Brian Francis
doaj  

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs

Clinical Ophthalmology, 2016
Jonathan S Lo,1 Pierre M Pang,2 Samuel C Lo3 1John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, 2MD-Pacific Eye Surgery Center, Honolulu, Hawaii, 3MD-Laser and Eye Surgery Center, Honolulu, Hawaii, USA Objective: Fixed ...
Lo JS, Pang PM, Lo SC
doaj  

Topical three-drug combination in the management of pseudophakic cystoid macular edema

Journal of Clinical Ophthalmology and Research
The purpose was to report the outcome after usage of three topical eyedrops combination, consisting of one steroid, one carbonic anhydrase inhibitor (CAI), and one non-steroidal anti-inflammatory drug (NSAID) in the treatment of pseudophakic cystoid ...
Siddharth Sane, Prabhushanker Mahalingam, Geetha Ganesan   +2 more
doaj   +1 more source

Twenty-four hour efficacy of glaucoma medications [PDF]

, 2015
Katsanos, Andreas, Konstas, Anastasios G. P., Mikropoulos, Dimitrios G., QUARANTA, Luciano, Teus, Miguel A., Tranos, Paris G.   +5 more
core   +1 more source

Ophthalmic Drugs 2015 [PDF]

A handy reference about ophthalmic drugs for students and clinicians in eye care ...
Helmus, Julie A, Koh, Len V
core   +1 more source

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2013
Ana Sanseau,1 Juan Sampaolesi,2 Emilio Rintaro Suzuki Jr,3 Joao Franca Lopes,4 Hector Borel51Instituto de la Visión, Ciudad de Buenos Aires, Argentina; 2Consultorio Oftalmologico Sampaolesi, Ciudad de Buenos Aires, Argentina; 3Oftalmoclinica ...
Sanseau A, Sampaolesi J, Suzuki Jr ER, Lopes JF, Borel H   +4 more
doaj  

Toxicodermias por beta-bloqueantes [PDF]

, 2019
La hipertensión arterial es una enfermedad crónica que disminuye la calidad y expectativa de vida, ya que se agrava la morbimortalidad cardiovascular y renal.
Pradillo Heras, Cristina
core  

Intravitreal aflibercept (Eylea) injection for cystoid macular edema secondary to retinitis pigmentosa - a first case report and short review of the literature [PDF]

, 2015

core   +1 more source

Corrigendum

Clinical Ophthalmology, 2011
Teus MA, Miglior S, Laganovska G, et al.Efficacy and safety of travoprost/ timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol.
Teus MA, Miglior S, Laganovska G, Volksone L, Romanowska-Dixon B, Gos R, Holló G; for the C-05-25 Study Group   +6 more
doaj